TDOC - Company ID 0001477449
The table below shows Teladoc Health, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $613.85M | $626.44M | $631.90M | $629.37M | $640.51M | $642.44M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $67.86M | $67.57M | $68.78M | $69.96M | $72.38M | $76.75M |
Teladoc Health, Inc. reported annual revenue of $2.53B for fiscal year 2025. That is down 1.5% from $2.57B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $123.16M (FY 2016) to $2.53B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $102.09M |
| $102.58M |
| $108.11M |
| $112.77M |
| $114.25M |
| $109.55M |
| Operating income | -$61.77M | -$51.96M | -$54.38M | -$120.61M | -$44.40M | -$841.15M |
| Income tax | $3.00M | -$715.00K | -$7.76M | -$18.25M | $780.00K | $3.88M |
| Net income | -$63.84M | -$49.51M | -$32.66M | -$93.01M | -$33.28M | -$837.67M |
| EPS (diluted) | -$0.36 | -$0.28 | -$0.19 | -$0.53 | -$0.19 | -$4.92 |